Literature DB >> 280153

Inhibition of influenza virus by triphenylmethane compounds.

D L Steward, J Martin, A P Grollman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 280153     DOI: 10.1111/j.1749-6632.1977.tb21998.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Effect of zinc and other chemical agents on foot-and-mouth-disease virus replication.

Authors:  J Polatnick; H L Bachrach
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

2.  Characterization of Aurintricarboxylic Acid (ATA) Interactions with Plasma Transporter Protein and SARS-CoV-2 Viral Targets: Correlation of Functional Activity and Binding Energetics.

Authors:  Conceição A Minetti; David P Remeta; Keiji Hashimoto; Radha Bonala; Rajesh Chennamshetti; Xingyu Yin; Miguel Garcia-Diaz; Arthur P Grollman; Francis Johnson; Viktoriya S Sidorenko
Journal:  Life (Basel)       Date:  2022-06-10

3.  Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.

Authors:  Anwar M Hashem; Anathea S Flaman; Aaron Farnsworth; Earl G Brown; Gary Van Domselaar; Runtao He; Xuguang Li
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

Review 4.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

5.  Aurintricarboxylic acid inhibits influenza virus neuraminidase.

Authors:  Hui-Chen Hung; Ching-Ping Tseng; Jinn-Moon Yang; Yi-Wei Ju; Sung-Nain Tseng; Yen-Fu Chen; Yu-Sheng Chao; Hsing-Pang Hsieh; Shin-Ru Shih; John T-A Hsu
Journal:  Antiviral Res       Date:  2008-11-17       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.